Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

61P First-line camrelizumab (Camre) plus carboplatin (Carbo) and pemetrexed (Pem) for advanced non-squamous NSCLC: 5-yr outcomes of CameL phase III study

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • بيانات النشر:
      Elsevier BV
    • الموضوع:
      2024
    • Collection:
      ScienceDirect (Elsevier - Open Access Articles via Crossref)
    • الرقم المعرف:
      10.1016/j.esmoop.2024.102640
    • Rights:
      https://www.elsevier.com/tdm/userlicense/1.0/ ; http://creativecommons.org/licenses/by-nc-nd/4.0/
    • الرقم المعرف:
      edsbas.3BC69BC4